As the global biotech sector gathers in San Diego for BIO 2026, MTPConnect is delighted to be partnering with the American Australian Association for a special BIO 2026 Dinner. Tickets available now
Read More
The Board of MTPConnect has appointed CEO Stuart Dignam as a Director.
Read More
MTPConnect and our AMR initiative, Australian Antimicrobial Resistance Network (AAMRNet), is stepping up, both here in Australia and internationally
Read More
Read the case study by Perth-based SME VitalTrace who is developing DevliAssure, real-time Fetal monitoring for safer childbirth with funding support through MTPConnect’s Clinical Translation and Commercialisation Medtech (CTCM) program.
Read More
Investment of $1 million from MTPConnect’s Clinical Translation and Commercialisation Medtech (CTCM) program has helped propel VividWhite’s novel surgical implant, VividFlo, towards becoming an improved long-term treatment option for people with glaucoma.
Read More
Case Study: Ventora Medical is developing an Airway Pressure Monitor that delivers non-invasive respiratory treatment for premature babies requiring neonatal intensive care support, with support from our CTCM program.
Read More
Atrial fibrillation (AF) is a most common heart rhythm disorder that can be treated with catheter ablation. CathRx, Australia’s only onshore designer and manufacturer of electrophysiology catheters, is developing an innovative pulsed field ablation technology to improve treatment with the help of MTPConnect’s CTCM accelerator.
Read More
The AUSCEP team caught up with AUSCEP mentor and medtech commercialisation expert, Tara Croft, to learn about Oli – a groundbreaking new medical device that is aiming to make pregnancy and childbirth safer and better for women.
Read More
Placing central venous catheters in newborns is one of the most delicate and error-prone procedures – Navi Medical Technologies is changing that with support from CTCM program, a MRFF initiative delivered by MTPConnect.
Read More
